巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Cara Therapeutics

    CARA
    9.620
    0.360
    3.89%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Cara Therapeutics - 延遲價格・最後更新於 29/06 12:14
    最高位
    9.630
    最低位
    9.000
    開市價
    --
    前收市價
    9.260
    成交量(千)
    17.62
    成交額(百萬)
    1.39
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    515.55
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    18.930 - 7.400
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Cara Therapeutics
    證券代碼
    CARA.US
    所屬板塊
    Biotechnology
    公司業務
    Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
    發行量
    53513518
    公司總部
    107 Elm Street, 9th Floor, 4 Stamford Plaza
    公司網址
    https://www.caratherapeutics.com
    公司電話
    +1 203 406-3700
    暫無內容

    關於

    Cara Therapeutics(CARA.US)所屬的行業板塊為Biotechnology。
    Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
    詳細公司背景可參考: https://www.caratherapeutics.com